Longboard Pharmaceuticals Inc (LBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,331 | 10,775 | 66,346 | 55,316 | N/A |
| Marketable Securities | 34,167 | 56,814 | 40,379 | N/A | N/A |
| TOTAL | $50,221 | $69,838 | $108,384 | $55,362 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4 | 9 | 14 | N/A | N/A |
| Other Non-Current Assets | 472 | 769 | 554 | 876 | 0 |
| TOTAL | $476 | $778 | $568 | $876 | $N/A |
| Total Assets | $50,697 | $70,616 | $108,952 | $56,238 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,001 | 1,310 | 1,028 | 1,213 | 0 |
| Accrued Expenses | 7,930 | 6,606 | 3,725 | 1,077 | N/A |
| TOTAL | $9,774 | $8,764 | $5,444 | $3,135 | $N/A |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 0 | 382 | 185 | 0 | 0 |
| TOTAL | $N/A | $382 | $185 | $N/A | $N/A |
| Total Liabilities | $9,774 | $9,146 | $5,629 | $3,135 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,017 | 22,965 | 17,215 | N/A | N/A |
| Common Shares | 2 | 1 | 1 | N/A | N/A |
| Retained earnings | -140,564 | -86,142 | -42,197 | -14,400 | N/A |
| Other shareholders' equity | -78 | -692 | -164 | 55,795 | 0 |
| TOTAL | $40,923 | $61,470 | $103,323 | $53,103 | $N/A |
| Total Liabilities And Equity | $50,697 | $70,616 | $108,952 | $56,238 | $0 |